Prognosis after surgical resection of non-small cell anaplastic bronchogenic lung carcinoma arising in the bronchi using new staging guidelines: Anaysis of 1,433 patients;Pronóstico tras resección quirúrgica del carcinoma broncogénico no anaplásico de células pequeñas según la nueva normativa de estadificación: Análisis de 1.433 pacientes

Archivos de Bronconeumologia

Volumn 35, Issue 10, 1999, Pages 483-487

  Padilla, J ^a   Calvo, V ^a   Garcia Zarza A ^a   Pastor, J ^a   Blasco, E ^a   Paris F ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Lung cancer; Staging; Surgery

Indexed keywords

ARTICLE; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; LUNG CARCINOMA; LUNG RESECTION; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SMALL CELL CARCINOMA; SPAIN; STATISTICS; SURVIVAL;

CARCINOMA, BRONCHOGENIC; CARCINOMA, SMALL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; SPAIN; SURVIVAL ANALYSIS;

EID: 0033218352     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-2896(15)30022-3     Document Type: Article

References (16)

1. Mountain CF. Revision in the International System for Staging Lund Cancer. Chest 1997; 111: 1.710-1.717.
2. Grupo de Trabajo de la SEPAR. Normativa actualizada (1998) sobre diagnóstico y estadificación del carcinoma broncogénico. Arch Bronconeumol 1998: 34: 437-452.
3. Rami-Porta R. Grupo Cooperativo de Carcinoma Broncogénico de la Sociedad Española de Neumología y Cirugía Torácica. Reflection on the revision in the international System for Stagingn Lung Cancer. Chest 1998; 113: 1.728-1.729.
4. Drings P, Bülzebruck H, Vogt-Moykopf I. Prognostic impact of the new 5th edition of the TNM classification for lung cancer (1997). Lung Cancer 1997; 18 (Supl 1): 215.
5. Inoue K, Sato M, Fujimura S, Sakurada A, Takahashi S, Usuda K et al. Prognostic assessment of 1,310 patients with non-small-cell-lung cancer who underwent complete resection from 1980 to 1993. J Thorac Cardiovasc Surg 1998: 116: 407-411.
6. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability of various levels of metastases in resected lung cancer. J Thorac Cardiovasc Surg 1978: 76: 832-839.
7. a ed.). Geneva: WHO, 1981.
8. Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988; 96: 440-447.
9. Ichinose Y, Hara N, Ohta M, Jano T, Maeda K, Asoh H et al. Is T factor of the TNM staging system a predominat prognostic factor in pathologic stage I non-small-cell lung cancer. A multivariate prognostic factor analysis of 151 patients. J Thorac Cardiovasc Surg 1993; 106: 90-94.
10. Izbicki JR, Passlick B, Pantel K, Pichlmeier W, Hosch SB, Kag O et al. Effectiveness of radical systematic mediastinal limphadenectomy in patients with resectable non-small cell lung cancer. Results of a prospective randomized trial. Ann Surg 1998; 227: 138-144.
11. Funatsu T, Matsubara Y, Ikeda S, Hatakenaka R, Hanawa T, Ishida H. Preoperative mediastinoscopic assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer. J Thorac Cardiovasc Surg 1994; 108: 321-328.
12. Little AG, DeHoyos A, Kirgan DM, Arcomano TR, Murray KD. Intraoperative lymphatic mapping for non-small cell lung cancer: the sentinel node technique. J Thorac Cardiovasc Surg 1999; 117: 220-224.
13. Detterbeck FC, Socinski MA. IIB or not IIB: the current question in staging non-small cell lung cancer. Chest 1997; 112: 229-234.
14. Sánchez de Cos Escuín J. Tratamiento actual del carcinoma broncopulmonar no microcítico y nueva clasificación TNM. Arch Bronconeumol 1999; 35: 94-96.
15. Bülzebruck H, Bopp R, Drings P, Bauer E. Krysa S. Probst G et al. New aspects in the staging lung cancer. Prospective validation of the international Union Against Cancer TNM classification. Cancer 1992; 70: 1.102-1.110.
16. Watanabe Y, Shimizu J, Oda M, Hayashi Y, Iwa T, Nonomura A et at. Proposals regarding some deficiencies in the new international staging system for non-small cell lung cancer. Jpn J Clin Oncol 1991: 21: 106-168.